Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution

Radiology

Volumn 198, Issue 3, 1996, Pages 795-805

  Kurhanewicz, John ^a,b   Vigneron, Daniel B ^a   Hricak, Hedvig ^a   Narayan, Perinchery ^a   Carroll, Peter ^a   Nelson, Sarah J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Magnetic resonance (MR), spectroscopy; Prostate, hyperplasia; Prostate, MR; Prostate, neoplasms

Indexed keywords

CHOLINE; CITRIC ACID; CREATINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLITE; OPTICAL RESOLUTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROTON NUCLEAR MAGNETIC RESONANCE; THREE DIMENSIONAL IMAGING;

EID: 0030056928     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.198.3.8628874     Document Type: Article

References (61)

1. Wingo PA, Tong T, Beiden S. Cancer statistics, 1995. CA Cancer J Clin 1995; 45:8-30.
2. McNeal J. The prostate gland: morphology and pathobiology. Monogr Urol 1983; 4:3-33.
3. Kahn T, Burrig K, Schmitz DB, Lewin JS, Furst G, Modder U. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. Radiology 1989; 173:847-851.
4. Benson MC, McMahon DJ, Cooner WH, Olsson CA. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density. World J Urol 1993; 11:206-213.
5. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 1992; 70(suppl 1):291-301.
6. Ling D, Lee JK, Heiken JP, Balfe DM, Glazer HS, McClennan BL. Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases. Radiology 1986; 158:103-107.
7. Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Radiology 1989; 172:131-137.
8. Ronnett BM, Carmichael MJ, Carter HB, Epstein JI. Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels? (article and comment). J Urol 1993; 150:386-389.
9. Kurhanewicz J, Dahiya R, Macdonald JM, Chang LH, James TL, Narayan P. Citrate alterations in primary and metastatic human prostatic adenocarcinomas: IH magnetic resonance spectroscopy and biochemical study. Magn Reson Med 1993; 29:149-157.
10. 31P MR spectroscopy. Magn Reson Med 1993; 29:244-248.
11. Yacoe ME, Sommer G, Peehl D. In vitro proton spectroscopy of normal and abnormal prostate. Magn Reson Med 1991; 19:429-438.
12. 1H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma. Magn Reson Med 1993; 29:285-291.
13. 31P magnetic resonance spectroscopy. J Urol 1993; 150: 2019-2024.
14. 1H NMR. Magn Reson Med 1992; 25:140-147.
15. Kurhanewicz J, Vigneron DB, Nelson SJ, et al. Citrate as a in vivo marker to discriminate prostatic cancer from benign prostatic hyperplasia and normal prostatic peripheral zone: detection via localized proton spectroscopy. Urology 1995; 45:1-9.
16. Stamey TA, McNeal JE, Freiha FS, Redwine E. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988; 139:1235-1241.
17. Walsh PC. Benign prostatic hyperplasia. In: Walsh PC, Gittes RF, Perlmutter AP, Stamey TA, eds. Campbell's urology. Philadelphia, Pa: Saunders, 1986; 1248-1265.
18. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 1993; 150:391-395.
19. Hricak H, White S, Vigneron D, et al. MR imaging in the staging of adenocarcinoma of the prostate: comparison between phased array and endorectal coil. Radiology 1994; 193:703-709.
20. Kier R, Wain S, Troiano R. Fast spin-echo MR images of the pelvis obtained with a phased-array coil: value in localizing and staging prostatic carcinoma. AJR 1993; 161: 601-606.
21. Parivar F, Rajanayagam V, Waluch V, Eto RT, Jones LW, Ross BD. Endorectal surface coil MR imaging of prostatic carcinoma with the inversion-recovery sequence. JMRI 1991; 1:657-664.
22. Schnall MD, Lenkinski RE, Pollack HM, Imai Y, Kressel HY. Prostate: MR imaging with an endorectal surface coil. Radiology 1989; 172:570-574.
23. 1H specrroscopy of the human prostate in-vivo (abstr). In: Book of abstracts: Society for Magnetic Resonance in Medicine 1990. Berkeley, Calif: Society for Magnetic Resonance in Medicine, 1990; 1:288.
24. 1H MR spectroscopy of normal and malignant human prostates in vivo. J Magn Reson 1990; 87:610-619.
25. Lowry M, Manton DJ, Liney GP, Blackband SJ, Turnbull LW, Horsman A. Citrate concentration correlates with water T2 in normal prostate (abstr). In: Book of abstracts, Society of Magnetic Resonance 1994. Berkeley, Calif: Society of Magnetic Resonance, 1994; 1:272.
26. 1H magnetic resonance in the identification and characterization of localized prostate cancer (abstr). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1994. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1994; 1:274.
27. Costello LC, Franklin RB. Concepts of citrate production and secretion by prostate. I. Metabolic relationships. Prostate 1991; 18:25-46.
28. Costello LC, Franklin RB. Concepts of citrate production and secretion by prostate. II. Hormonal relationships in normal and neoplastic prostate. Prostate 1991; 19: 181-205.
29. Cooper JF, Farid I. The role of citric acid in the physiology of the prostate. III. Lactate/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy. J Urol 1964; 92:533-535.
30. Costello LC, Littleton GK, Franklin RB. Regulation of citrate-related metabolism in normal and neoplastic prostate. In: Sharma RK, Criss WE, eds. Endocrine control in neoplasia. New York, NY: Raven, 1978; 303-314.
31. Schick F, Bongers H, Kurz S, Jung WI, Pfeffer M, Lutz O. Localized proton MR spectrescopy of citrate in vitro and of the prostate in vivo at 1.5 T. Magn Reson Med 1993; 29:38-43.
32. 13C NMR spectroscopy of the human prostate. Magn Reson Med 1988; 8:224-230.
33. 13C NMR spectroscopy. Magn Reson Med 1988; 7:384-411.
34. 31P magnetic resonance spectroscopy: possible clinical significance. Mayo Clin Proc 1988; 63:1199-1207.
35. 31P NMR spectroscopy. J Biol Chem 1987; 262:14875-14878.
36. Galons JP, Fantini J, Vion DJ, Cozzone PJ, Canioni P. Metabolic changes in undifferentiated and differentiated human colon adenocarcinoma cells studied by multinuclear magnetic resonance spectroscopy. Biochimie 1989; 71:949-961.
37. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992; 5:303-324.
38. Sijens PE, van Dijk DP, Oudkerk M. Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma. Magn Reson Med 1994; 32:549-555.
39. 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 1994; 18:705-713.
40. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 1982; 79:3523-3526.
41. Maudsley AA, Hilal SK, Simon HE, Wittekoek S. In vivo MR spectroscopic imaging with P-31: work in progress. Radiology 1984; 153:745-750.
42. Bracewell RN. The Fourier transform and its applications. New York, NY: McGraw-Hill, 1978; 104-107.
43. Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone MM. The TNM classification of prostate cancer. Prostate 1992; 4(suppl):129-138.
44. Nghiem HV, Herfkens RJ, Francis IR, et al. The pelvis: T2-weighted fast spin-echo MR imaging. Radiology 1992; 185:213-217.
45. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using echoes: initial applications to human brain in vivo. Magn Reson Med 1989; 9:79-93.
46. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987; 508:333-348.
47. Pauly J, Le Roux P, Nishimura D, Macovski A. Parameter relations for the Shinnar-Le Roux selective excitation pulse design algorithm IEEE Trans Med Imaging 1991; 10: 53-65.
48. Mulkern RV, Bowers JL. Calculating spectral modulations of AB systems during PRESS acquisitions (letter, comment). Magn Reson Med 1993; 30:518.
49. 1H spectroscopy (abstr). In: Book of abstracts, Society for Experimental Nuclear Magnetic Resonance Spectroscopy 1992. Sante Fe, NM: Society for Experimental Nuclear Magnetic Resonance Spectroscopy, 1992; 203.
50. 1H MRS data for the assessment of response to therapy in patients with brain tumors (abstr). In: Book of abstracts, Society of Magnetic Resonance 1995. Berkeley, Calif: Society of Magnetic Resonance, 1995; 1960.
51. Moyher SE, Vigneron DB, Nelson SJ. Surface coil MR imaging of the human brain with an analytic reception profile correction. JMRI 1995; 5:139-144.
52. Vigneron DB, Nelson SJ, Moyher S, Kelley DAC, Kurhanewicz J, Hricak H. An analytical correction of MR images obtained with endorectal or surface coils (abstr). In: Book of abstracts, Society of Magnetic Resonance Imaging 1993. San Francisco, Calif: Society of Magnetic Resonance Imaging, 1993; 3(P):142.
53. Nelson SJ, Brown TR. A new method for automatic quantification of 1-D spectra with low signal to noise ratio. J Magn Reson 1987; 75:229-243.
54. Nelson S, Brown T. A study of the accuracy of quantification which can be obtained from 1-D NMR spectra using the PIQABLE algorithm. J Magn Reson 1989; 84:95-109.
55. White S, Hricak H, Kurhanewicz J, et al. Prostate cancer: impact of postbiopsy hemorrhage on MR interpretation. Radiology 1995; 195:385-390.
56. Hricak H. The prostate gland. In: Hricak H, Carrington BM, eds. MRI of the pelvis. London, England: Dunitz, 1991; 249-311.
57. Lynch MJ, Masters J, Pryor JP, et al. Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. J Pharm Biomed Anal 1994; 12:5-19.
58. 31P magnetic resonance spectroscopy and high pressure liquid chromatography. NMR Biomed 1992; 5:185-192.
59. Narayan P, Jajodia P, Kurhanewicz J, et al. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal phosphorus magnetic resonance spectroscopy: a preliminary report. J Urol 1991; 146:66-74.
60. McNeal JE, Kindrachuk RA, Freiha FS, Bostwick DG, Redwine EA, Stamey TA. Patterns of progression in prostate cancer. Lancet 1986; 1:60-63.
61. Marberger H, Marberger E, Mann T, Lutwak-Mann C. Citric acid in human prostatic secretion and metastasizing cancer of prostate gland. Br Med J 1962; 1:835-836.